Next Generation Research Grant in ALS supports early-career investigators studying ALS mechanisms, diagnosis, or treatment to advance research with potential relevance to other diseases.
Funder: American Brain Foundation
Due Dates: October 8, 2026, at 5:00 PM CT (Application deadline)
Funding Amounts: $150,000 over two years ($75,000 annually), July 1, 2027–June 30, 2029
Summary: Supports early-career investigators conducting clinical or preclinical research on ALS mechanisms, diagnosis, or treatment with potential relevance to other diseases.
Key Information: Applicants must have completed clinical residency or a PhD in 2022 or later and have 70% protected research time.
The Next Generation Research Grant in ALS is funded jointly by The ALS Association and American Brain Foundation and administered by the American Brain Foundation. This two-year award supports early-career investigators pursuing clinical or preclinical studies of ALS disease mechanisms, diagnosis, or treatment. Proposed research should have potential relevance beyond ALS, reflecting the foundation’s Cure One, Cure Many philosophy that breakthroughs in one disease can accelerate progress across others.
The program prioritizes testable hypotheses, innovation, methodological rigor, clinical impact, and translational value. It also emphasizes feasible research aims and committed mentorship that helps applicants develop toward independent research careers. The foundation supports research incorporating broad perspectives and study populations reflecting the full spectrum of people affected by ALS.